Bank of Montreal
AMPE

Bank of Montreal’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Bank of Montreal’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-89
Closed -$94K – 4226
2014
Q3 		$94K Buy
+89
New +$150K ﹤0.01% 2855

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of Montreal's AMPE Position: Q2 2022 in Review

Bank of Montreal sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2022, closing a stake of 1,200 shares — an estimated $168K sold.

Bank of Montreal first reported a position in AMPE in Q2 2014 and held it in 12 quarters. The position peaked at $662K in Q1 2021. 111 funds tracked by Wall St. Rank hold AMPE as of Q2 2022.

  • Bank of Montreal reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2022 after selling out during the quarter.
  • Bank of Montreal sold 1,200 Ampio Pharmaceuticals Inc. shares in Q2 2022, an estimated $168K.
  • Bank of Montreal first reported a position in Ampio Pharmaceuticals Inc. in Q2 2014 and held it in 12 quarters.
  • Bank of Montreal's Ampio Pharmaceuticals Inc. position peaked at $662K in Q1 2021.
  • 111 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2022.

Based on Bank of Montreal's 13F filing for Q2 2022, filed 11 Aug 2022.